MDL | MFCD00242707 |
---|---|
Molecular Weight | 335.87 |
Molecular Formula | C18H26ClN3O |
SMILES | ClC1=CC=C2C(NC(CCCN(CCO)CC)C)=CC=NC2=C1 |
Hydroxychloroquine is a synthetic antimalarial agent which can also inhibit Toll-like receptor 7/9 ( TLR7/9 ) signaling. Hydroxychloroquine is efficiently inhibits SARS-CoV-2 infection in vitro [1] [2] [3] .
Plasmodium |
NCT Number | Sponsor | Condition | Start Date | Phase |
---|---|---|---|---|
NCT03229746 | Assiut University |
Immune Thrombocytopenia
|
August 1, 2017 | Phase 4 |
NCT04325893 | University Hospital, Angers |
Coronavirus
|
April 1, 2020 | Phase 3 |
NCT04447534 | Tanta University |
COVID
|
June 23, 2020 | Phase 3 |
NCT04554979 | Cairo University |
Covid19|Diarrhea
|
June 1, 2020 | |
NCT04363203 | Salomeh Keyhani MD|San Francisco VA Health Care System |
SARS-CoV-2|COVID-19
|
April 30, 2020 | Phase 3 |
NCT02026232 | Washington University School of Medicine |
Type 2 Diabetes Mellitus
|
March 2012 | Not Applicable |
NCT04593758 | Cornerstone Pharmaceuticals |
Sarcoma, Clear Cell
|
September 1, 2021 | Phase 1|Phase 2 |
NCT03598595 | M.D. Anderson Cancer Center|National Cancer Institute (NCI) |
Recurrent Osteosarcoma|Refractory Osteosarcoma
|
January 28, 2019 | Phase 1|Phase 2 |
NCT04352933 | Cambridge University Hospitals NHS Foundation Trust |
COVID-19
|
May 11, 2020 | Phase 3 |
NCT04355052 | Sheba Medical Center |
COVID - 19
|
April 11, 2020 | Phase 3 |
NCT04323631 | Rambam Health Care Campus|Rabin Medical Center |
COVID-19
|
April 30, 2020 | Early Phase 1 |
NCT01148043 | Maasstad Hospital |
Osteoarthritis
|
July 2010 | Phase 3 |
NCT04605588 | Rutgers, The State University of New Jersey|SynaVir |
SARS-CoV Infection|Covid19
|
December 2, 2020 | Phase 2 |
NCT02257424 | Abramson Cancer Center of the University of Pennsylvania |
Advanced BRAF Mutant Melanoma
|
October 2014 | Phase 1|Phase 2 |
NCT04911816 | West Virginia University |
Adenocarcinoma of the Pancreas
|
July 16, 2021 | Phase 1|Phase 2 |
NCT04366089 | Roberto Poscia MD, PhD|Azienda Policlinico Umberto I |
COVID|SARS-CoV 2|Pneumonia, Viral|Coronavirus Infection
|
March 26, 2020 | Phase 2 |
NCT04411433 | Ministry of Health, Turkey|Hacettepe University, Faculty of Medicine|Prof. Dr. Cemil Tasc?oglu Education and Research Hospital Organization|Umraniye Education and Research Hospital|SB Istanbul Education and Research Hospital|Sultan Abdulhamid Han Training and Research Hospital, Istanbul, Turkey|Tepecik Training and Research Hospital|Istanbul University-Cerrahpasa, Cerrahpasa Faculty of Medicine|Ankara University|Ankara City Hospital Bilkent|Ankara Training and Research Hospital|Ege University Hospital (Application and Research Center)|Kocaeli Derince Education and Research Hospital|Istanbul University|Kayseri City Hospital |
Sars-CoV2|COVID-19
|
May 8, 2020 | Phase 3 |
NCT04389320 | Assiut University |
Rheumatoid Arthritis
|
March 15, 2020 | |
NCT02475915 | South East Asia Research Collaboration with Hawaii|The Thai Red Cross AIDS Research Centre|Cooper Human Systems |
Acute HIV Infection
|
January 2015 | Phase 1|Phase 2 |
NCT02648464 | Helsinki University Central Hospital|Finnish Foundation for Cardiovascular Research|Orion Corporation, Orion Pharma|Aarne Koskelo Foundation|Finnish Cultural Foundation |
Myocardial Infarction|Acute Coronary Syndrome|Inflammation|Hydroxychloroquine|Antirheumatic Agents|Cardiovascular Diseases
|
February 1, 2016 | Phase 4 |
NCT00486603 | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins|National Cancer Institute (NCI) |
Brain and Central Nervous System Tumors
|
October 29, 2007 | Phase 1|Phase 2 |
NCT04361461 | Apsen Farmaceutica S.A.|Federal University of São Paulo |
Coronavirus Infections|SARS-CoV 2|SARS (Severe Acute Respiratory Syndrome)|Pulmonary Disease
|
April 30, 2020 | Phase 3 |
NCT04459702 | ProgenaBiome|Big Corona Ltd. |
COVID|COVID-19|Corona Virus Infection|Coronavirus Infection|Coronavirus Sars-Associated as Cause of Disease Classified Elsewhere|Coronavirus-19|SARS-CoV 2|SARS Pneumonia
|
July 2020 | Phase 2 |
NCT04372017 | Sanford Health |
COVID-19|SARS-CoV 2
|
May 14, 2020 | Phase 3 |
NCT02644499 | Jawaharlal Institute of Postgraduate Medical Education & Research |
Rheumatoid Arthritis
|
December 31, 2015 | Phase 4 |
NCT02942381 | Peking University First Hospital |
IgA Patients|Hydroxychloroquine
|
September 13, 2016 | Phase 2 |
NCT01760421 | National Taiwan University Hospital |
Hashimoto Thyroiditis
|
October 2011 | Not Applicable |
NCT04351919 | Abderrahmane Mami Hospital|Eshmoun Clinical Research Center|Dacima Consulting |
Patients With COVID19
|
May 5, 2020 | Phase 4 |
NCT05024006 | University of the Philippines |
Covid19
|
April 23, 2020 | Not Applicable |
NCT00786682 | University of Medicine and Dentistry of New Jersey|National Cancer Institute (NCI)|Rutgers, The State University of New Jersey |
Prostate Cancer
|
December 2008 | Phase 2 |
NCT02414776 | Western Regional Medical Center |
Estrogen Receptor Positive Breast Cancer
|
July 2014 | Phase 1 |
NCT03687905 | Tanta University |
Proliferative Nephritis|Chloroquine Retinopathy
|
September 18, 2018 | |
NCT04380818 | Grupo de Investigación Clínica en Oncología Radioterapia|Hospital Universitario Madrid Sanchinarro|Hospital del Mar|Hospital Universitari Sant Joan de Reus |
Pneumonia, Viral
|
June 5, 2020 | Not Applicable |
NCT05083780 | Changhoon Yoo|Oncocross Co. Ltd.|CytoGen, Inc.|Asan Medical Center |
Pancreatic Cancer
|
November 30, 2021 | Phase 1 |
NCT03929211 | Wake Forest University Health Sciences|National Cancer Institute (NCI) |
Myelodysplastic Syndromes|Progressive Disease
|
May 2021 | Phase 1|Phase 2 |
NCT04351516 | University Hospital Tuebingen |
SARS-CoV 2|COVID-19
|
April 21, 2020 | Phase 2|Phase 3 |
NCT04316169 | Medical College of Wisconsin |
Solid Tumor|Advanced Breast Cancer
|
October 21, 2021 | Phase 1 |
NCT00765765 | University of Medicine and Dentistry of New Jersey|National Cancer Institute (NCI)|Rutgers, The State University of New Jersey |
Breast Cancer
|
February 2009 | Phase 1|Phase 2 |
NCT03774472 | M.D. Anderson Cancer Center |
Anatomic Stage I Breast Cancer AJCC v8|Anatomic Stage IA Breast Cancer AJCC v8|Anatomic Stage IB Breast Cancer AJCC v8|Anatomic Stage II Breast Cancer AJCC v8|Anatomic Stage IIA Breast Cancer AJCC v8|Anatomic Stage IIB Breast Cancer AJCC v8|Anatomic Stage III Breast Cancer AJCC v8|Anatomic Stage IIIA Breast Cancer AJCC v8|Anatomic Stage IIIB Breast Cancer AJCC v8|Anatomic Stage IIIC Breast Cancer AJCC v8|Anatomic Stage IV Breast Cancer AJCC v8|Prognostic Stage I Breast Cancer AJCC v8|Prognostic Stage IA Breast Cancer AJCC v8|Prognostic Stage IB Breast Cancer AJCC v8|Prognostic Stage IIA Breast Cancer AJCC v8|Prognostic Stage IIB Breast Cancer AJCC v8|Prognostic Stage III Breast Cancer AJCC v8|Prognostic Stage IIIA Breast Cancer AJCC v8|Prognostic Stage IIIB Breast Cancer AJCC v8|Prognostic Stage IIIC Breast Cancer AJCC v8|Prognostic Stage IV Breast Cancer AJCC v8
|
August 20, 2018 | Phase 1|Phase 2 |
NCT04384458 | Nucleo De Pesquisa E Desenvolvimento De Medicamentos Da Universidade Federal Do Ceara |
Coronavirus Infections
|
July 20, 2020 | Not Applicable |
NCT04715295 | Yaounde Central Hospital |
COVID-19
|
October 5, 2020 | Phase 4 |
NCT04347889 | Stony Brook University |
Covid-19
|
April 20, 2020 | Phase 2 |
NCT04345692 | Queen´s Medical Center |
COVID-19
|
March 26, 2020 | Phase 3 |
NCT04365582 | Groupe Hospitalier Paris Saint Joseph |
COVID
|
May 7, 2020 | Phase 3 |
NCT04523857 | Abramson Cancer Center of the University of Pennsylvania |
Breast Cancer
|
November 1, 2021 | Phase 2 |
NCT01551069 | Sanofi |
Cutaneous Lupus Erythematosus-Systemic Lupus Erythematosus
|
March 2012 | Phase 3 |
NCT04328285 | Centre Hospitalier Universitaire de Saint Etienne|Institut Pasteur |
COVID-19
|
April 14, 2020 | Phase 3 |
NCT03122431 | University of Sao Paulo General Hospital|Fundação de Amparo à Pesquisa do Estado de São Paulo |
Systemic Lupus Erythematosus (SLE)|Juvenile SLE|Cutaneous Lupus
|
June 5, 2017 | Phase 4 |
NCT04315896 | National Institute of Respiratory Diseases, Mexico |
COVID-19|Severe Acute Respiratory Syndrome
|
April 14, 2020 | Phase 3 |
NCT04163107 | Norwegian University of Science and Technology|St. Olavs Hospital|Oslo University Hospital |
Multiple Myeloma
|
January 7, 2020 | Phase 1 |
NCT04405921 | Centre Hôpital Universitaire Farhat Hached |
SARS-CoV-2 Pneumonia|COVID-19
|
July 2020 | Phase 3 |
NCT04339816 | Frantisek Duska, MD, PhD|Masaryk Hospital Usti nad Labem|University Hospital Pilsen|The Faculty Hospital Na Bulovce|St. Anne´s University Hospital Brno, Czech Republic|University Hospital, Motol|General University Hospital, Prague|University Hospital Olomouc|Charles University, Czech Republic |
COVID-19|Respiratory Failure
|
May 13, 2020 | Phase 3 |
NCT01040195 | Sanjay Gandhi Postgraduate Institute of Medical Sciences |
Seronegative Spondyloarthropathies
|
June 2009 | Phase 3 |
NCT04652648 | Bryn Mawr Hospital|Sharpe-Strumia Research Foundation|Bryn Mawr Hospital Foundation|Cotswold Foundation |
Covid19|Hydroxychloroquine|Coronavirus Infection|Transmission|Prophylaxis
|
May 27, 2020 | Phase 4 |
NCT04937907 | Shanghai Children´s Hospital |
Alport Syndrome, X-Linked
|
September 8, 2021 | Phase 2 |
NCT04364815 | University of the Philippines |
COVID-19
|
December 2020 | Phase 3 |
NCT00726596 | Rutgers, The State University of New Jersey|Rutgers Cancer Institute of New Jersey|National Cancer Institute (NCI) |
Prostate Cancer
|
August 2008 | Phase 2 |
NCT04597775 | Regional Center for Disease Control and Prevention, Jordan|Farhat Hached Hospital, Tunisia|Fattouma Bourguiba, Tunisia |
SARS-CoV Infection
|
October 27, 2020 | Phase 2|Phase 3 |
NCT01709578 | Sanofi|Regeneron Pharmaceuticals |
Rheumatoid Arthritis
|
October 2012 | Phase 3 |
NCT04334148 | Adrian Hernandez|Patient-Centered Outcomes Research Institute|Duke University |
COVID-19
|
April 22, 2020 | Phase 3 |
NCT04360759 | University of Cape Town |
Covid-19|HIV
|
May 1, 2020 | Phase 3 |
NCT04381936 | University of Oxford|UK Research and Innovation|National Institute for Health Research, United Kingdom|Wellcome|Bill and Melinda Gates Foundation|Department for International Development, United Kingdom|Health Data Research UK|Medical Research Council Population Health Research Unit|NIHR Clinical Trials Unit Support Funding|NIHR Health Protection Research Unit in Emerging and Zoonotic Infections |
Severe Acute Respiratory Syndrome
|
March 19, 2020 | Phase 2|Phase 3 |
NCT04389359 | Cambridge University Hospitals NHS Foundation Trust|University of Cambridge |
COVID-19
|
September 2020 | Phase 2|Phase 3 |
NCT04145297 | University of Utah|BioMed Valley Discoveries, Inc |
Gastrointestinal Neoplasms
|
March 17, 2020 | Phase 1 |
NCT01978184 | Nathan Bahary, MD|University of Pittsburgh |
Pancreatic Cancer
|
November 2013 | Phase 2 |
NCT02466581 | Karolinska Institutet |
Rheumatoid Arthritis
|
February 3, 2015 | Phase 4 |
NCT04788355 | Universidade do Vale do Sapucai|Pfizer|Apsen Farmaceutica S.A.|Dermadia|Methodos Laboratory|Biofarma |
Complication
|
July 1, 2020 | Phase 3 |
NCT04005781 | Universitaire Ziekenhuizen KU Leuven |
Obesity
|
October 1, 2019 | Phase 4 |
NCT03180190 | Assiut University |
Autoimmune Diseases
|
June 28, 2017 | |
NCT05221320 | BioMed Valley Discoveries, Inc |
Tumor, Solid|Gastrointestinal Cancer
|
May 26, 2022 | Phase 2 |
NCT04420247 | Centro de Estudos e Pesquisa em Emergencias Medicas e Terapia Intensiva |
COVID|COVID-19|SARS-CoV 2|Coronavirus|Corona Virus Infection
|
April 16, 2020 | Phase 3 |
NCT01132118 | Brigham and Women´s Hospital|National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) |
Rheumatoid Arthritis|Insulin Resistance
|
June 2010 | Phase 3 |
NCT04342169 | University of Utah |
Coronavirus Infection|Coronavirus|Infectious Disease
|
April 4, 2020 | Phase 2 |
NCT04334928 | Plan Nacional sobre el Sida (PNS)|Effice Servicios Para la Investigacion S.L. |
Coronavirus Infection
|
April 15, 2020 | Phase 3 |
NCT04372082 | University Hospital, Lille|I-site University Lille North Europe |
Sars-CoV2
|
May 2020 | Phase 3 |
NCT01144169 | University of Pittsburgh|National Institutes of Health (NIH) |
Renal Cell Carcinoma
|
October 2010 | Phase 1 |
NCT04331834 | Barcelona Institute for Global Health|Hospital Clinic of Barcelona|Laboratorios Rubió|Fundació Institut de Recerca de l´Hospital de la Santa Creu i Sant Pau|Hospital Plató|Hospital de Granollers |
COVID-19
|
April 3, 2020 | Phase 3 |
NCT00809237 | National University Hospital, Singapore|Massachusetts General Hospital|AstraZeneca |
Non-small Cell Lung Cancer
|
November 2008 | Phase 1|Phase 2 |
NCT01783106 | Royal Liverpool University Hospital|National Association for Colitis and Crohn´s Disease|National Institute for Health Research, United Kingdom |
Crohn´s Disease
|
February 1, 2014 | Phase 2 |
NCT05113004 | Assistance Publique - Hôpitaux de Paris |
Primary Sjögren´s Syndrome (pSS)
|
January 20, 2022 | Phase 2 |
NCT05016297 | Peking Union Medical College Hospital|Eli Lilly and Company |
Sjogren´s Syndrome
|
July 14, 2022 | Phase 2 |
NCT01326533 | University of Pittsburgh|National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) |
Pre-diabetes
|
March 2011 | Phase 4 |
NCT04358068 | National Institute of Allergy and Infectious Diseases (NIAID)|Teva Pharmaceutical Industries, Ltd. |
COVID-19|SARS-CoV 2
|
May 13, 2020 | Phase 2 |
NCT05576896 | Northwestern University|National Cancer Institute (NCI) |
Stage IV Colorectal Cancer Positive for BRAF V600E Mutation|Colorectal Cancer|Colorectal Cancer Stage IV
|
October 10, 2022 | Phase 2 |
NCT02057250 | Sanofi|Regeneron Pharmaceuticals |
RA
|
March 2014 | Phase 3 |
NCT04344457 | Perseverance Research Center, LLC|Athena Medical Group |
COVID-19
|
April 16, 2020 | Phase 1|Phase 2 |
NCT04341493 | Hugo Mendieta Zeron|Materno-Perinatal Hospital of the State of Mexico |
Coronavirus Infection
|
April 6, 2020 | Phase 4 |
NCT05013463 | University of Calgary |
Multiple Sclerosis, Secondary Progressive
|
October 1, 2021 | Phase 2 |
NCT04370782 | St. Francis Hospital, New York |
COVID-19
|
April 28, 2020 | Phase 4 |
NCT04350450 | Montefiore Medical Center |
COVID|Coronavirus|COVID-19
|
April 2020 | Phase 2 |
NCT04120883 | University of Michigan|Cures Within Reach |
Retinitis Pigmentosa
|
February 25, 2020 | Phase 1|Phase 2 |
NCT04341727 | Washington University School of Medicine |
Coronavirus Infection
|
April 4, 2020 | Phase 3 |
NCT02351752 | LLiu|Peking University First Hospital |
Primary IgA Nephropathy
|
January 2015 | Phase 4 |
NCT01687179 | Brigham and Women´s Hospital|National Heart, Lung, and Blood Institute (NHLBI) |
Lymphangioleiomyomatosis
|
September 2012 | Phase 1 |
NCT01067417 | Medical Research Council|Wellcome Trust |
HIV Infections
|
June 2008 | Phase 2 |
NCT01023737 | Sukeshi Patel|Merck Sharp & Dohme LLC|The University of Texas Health Science Center at San Antonio |
Malignant Solid Tumour
|
November 2009 | Phase 1 |
NCT05311813 | Beni-Suef University |
COVID-19 Pandemic
|
June 1, 2021 | Not Applicable |
NCT04381988 | Memorial Sloan Kettering Cancer Center |
COVID-19|Cancer
|
May 7, 2020 | Phase 2 |
NCT04397328 | Lawson Health Research Institute |
COVID-19
|
May 19, 2020 | Phase 3 |
NCT04007562 | Assistance Publique - Hôpitaux de Paris |
LIPIN1 Deficiency
|
July 2019 | |
NCT04461353 | Pulmoquine Therapeutics, Inc|Rockefeller University |
Severe Acute Respiratory Syndrome Coronavirus 2
|
June 25, 2020 | Phase 1 |
NCT02079077 | University of Manitoba|University of Nairobi |
HIV
|
April 2014 | Not Applicable |
NCT04334382 | Intermountain Health Care, Inc.|University of Utah|Utah Department of Health |
COVID-19
|
April 2, 2020 | Phase 3 |
NCT03165136 | University Hospital, Brest |
Recurrent Miscarriage|First Trimester Abortion
|
December 4, 2017 | Phase 3 |
NCT01073852 | Vanderbilt University |
Chronic Urticaria
|
June 2011 | Not Applicable |
NCT04392128 | Institut de cancérologie Strasbourg Europe |
COVID19|Hematologic Malignancy
|
September 2, 2020 | Phase 2 |
NCT02874287 | First Affiliated Hospital Xi´an Jiaotong University |
Coronary Artery Disease
|
October 8, 2017 | Phase 4 |
NCT04668469 | Benha University |
Covid19
|
June 8, 2020 | Not Applicable |
NCT04348474 | Azidus Brasil |
Covid-19
|
April 20, 2020 | Early Phase 1 |
NCT03030118 | Milton S. Hershey Medical Center|National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) |
Systemic Lupus Erythematosus
|
December 28, 2017 | Phase 2 |
NCT00405275 | US Department of Veterans Affairs|Canadian Institutes of Health Research (CIHR)|Rheumatoid Arthritis Investigational Network (RAIN)|National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)|VA Office of Research and Development |
Rheumatoid Arthritis
|
July 2007 | Not Applicable |
NCT04342221 | University Hospital Tuebingen|Robert Bosch Medical Center|Universitätsklinikum Hamburg-Eppendorf|Bernhard Nocht Institute for Tropical Medicine |
COVID-19, Hydroxychloroquine Sulfate
|
March 29, 2020 | Phase 3 |
NCT04384380 | Taoyuan General Hospital|Center for Drug Evaluation, Taiwan|Centers for Disease Control, Taiwan|Taiwan Food and Drug Administration|National Health Research Institutes, Taiwan |
Coronavirus Infection
|
April 1, 2020 | Not Applicable |
NCT01784523 | Hospital for Special Surgery, New York|AntiPhospholipid Syndrome Alliance For Clinical Trials and InternatiOnal Networking|The New York Community Trust |
Antiphospholipid Syndrome
|
February 2013 | Phase 3 |
NCT05247554 | Assistance Publique - Hôpitaux de Paris |
Pulmonary Sarcoidosis
|
March 1, 2022 | Phase 3 |
NCT00176982 | Hordinsky, Maria K., MD|University of Minnesota |
Alopecia Areata
|
April 2002 | Phase 4 |
NCT01601028 | Seoul National University Hospital |
Autoimmune Diseases|Sjogren´s Syndrome|Dry Eye
|
July 2011 | Phase 3 |
NCT03449758 | Sanofi|Regeneron Pharmaceuticals |
Rheumatoid Arthritis
|
March 5, 2018 | Phase 4 |
NCT02765594 | Peking Union Medical College Hospital |
Primary IgA Nephropathy
|
June 2016 | Phase 4 |
NCT01828476 | Rutgers, The State University of New Jersey|Rutgers Cancer Institute of New Jersey|National Cancer Institute (NCI)|AbbVie |
Prostate Cancer
|
June 2013 | Phase 2 |
NCT01649947 | Rutgers, The State University of New Jersey|National Cancer Institute (NCI)|Rutgers Cancer Institute of New Jersey |
Non-small Cell Lung Cancer|Advanced Non-small Cell Lung Cancer|Recurrent Non-small Cell Lung Cancer
|
December 23, 2011 | Phase 2 |
NCT04329572 | Azidus Brasil |
COVID-19
|
April 23, 2020 | Early Phase 1 |
NCT01768572 | Sanofi|Regeneron Pharmaceuticals |
Rheumatoid Arthritis
|
March 2013 | Phase 3 |
NCT03283566 | The Cleveland Clinic|Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute)|Stanford University |
Chronic Pancreatitis|Insulin Dependent Diabetes
|
October 3, 2017 | Phase 2 |
NCT04410562 | Barcelona Institute for Global Health|Hospital Clinic of Barcelona|Fundació Institut de Recerca de l´Hospital de la Santa Creu i Sant Pau|University Hospital of Torrejon|Fundación de investigación HM|Hospital Sant Joan de Deu|Hospital del Mar|Hospital Universitario Infanta Leonor|Hospital Universitario Fundación Alcorcón|Hospital General de Segovia|Institut Català de la Salut |
Pregnancy Related|COVID|Covid-19
|
May 13, 2020 | Phase 3 |
NCT04359316 | Shahid Beheshti University of Medical Sciences |
COVID-19
|
April 20, 2020 | Phase 4 |
NCT04359615 | Shahid Beheshti University of Medical Sciences |
COVID-19
|
April 20, 2020 | Phase 4 |
NCT04918524 | Qilu Hospital of Shandong University |
Connective Tissue Diseases|Pregnancy Related
|
September 11, 2018 | |
NCT05119140 | Icahn School of Medicine at Mount Sinai|Crohn´s and Colitis Foundation |
Ulcerative Colitis (Disorder)
|
June 10, 2022 | Phase 1|Phase 2 |
NCT04328961 | University of Washington|Bill and Melinda Gates Foundation |
COVID-19|Corona Virus Infection|SARS (Severe Acute Respiratory Syndrome)|SARS-CoV-2
|
March 31, 2020 | Phase 2|Phase 3 |
NCT01379573 | NYU Langone Health |
Congenital Heart Block|Neonatal Lupus|Autoantibody-Associated Heart Block
|
January 1, 2011 | Phase 2 |
NCT04333654 | Sanofi |
Coronavirus Infection
|
April 12, 2020 | Phase 1 |
NCT01946880 | National Institute of Allergy and Infectious Diseases (NIAID)|Autoimmunity Centers of Excellence|Rho Federal Systems Division, Inc. |
Systemic Lupus Erythematosus|SLE
|
November 20, 2013 | Phase 2 |
NCT04365231 | Hospital St. Joseph, Marseille, France |
COVID19
|
April 1, 2020 | Phase 3 |
NCT04334512 | ProgenaBiome|DSCS CRO |
COVID-19|Corona Virus Infection|Coronavirus-19|Sars-CoV2
|
June 22, 2020 | Phase 2 |
NCT04351191 | Government of Punjab, Specialized Healthcare and Medical Education Department|Mayo Hospital Lahore|Services Hospital, Lahore|Pakistan Kidney and Liver Institute |
Sars-CoV2|Symptomatic Condition|Covid-19
|
April 15, 2020 | Phase 4 |
NCT04354870 | NYU Langone Health |
COVID-19
|
April 3, 2020 | Phase 2 |
NCT02379650 | University of Utah|Intermountain Health Care, Inc. |
Recurrent Pregnancy Loss|Miscarriage
|
July 2016 | Phase 2 |
NCT01602588 | University College, London|Cancer Research UK |
Glioblastoma
|
May 2013 | Phase 2 |
NCT02374021 | Brigham and Women´s Hospital|Columbia University |
Arthritis, Rheumatoid
|
July 2016 | Phase 4 |
NCT04712279 | Corpometria Institute |
Covid19
|
January 25, 2021 | Phase 2|Phase 3 |
NCT05126147 | National Taiwan University Hospital |
Graves Ophthalmopathy
|
December 1, 2021 | Phase 4 |
NCT04691505 | Brigham and Women´s Hospital|National Institute on Aging (NIA)|Rutgers University|Johns Hopkins University |
Rheumatoid Arthritis
|
December 23, 2020 | |
NCT04466280 | Baqiyatallah Medical Sciences University |
COVID-19
|
August 12, 2020 | Not Applicable |
NCT04344444 | LCMC Health |
COVID-19
|
April 13, 2020 | Phase 3 |
NCT04353336 | Tanta University |
COVID-19|Coronavirus Infection
|
March 23, 2020 | Phase 2|Phase 3 |
NCT03825289 | University of Utah|Novartis Pharmaceuticals |
Metastatic Pancreatic Carcinoma|Stage II Pancreatic Cancer|Stage IIA Pancreatic Cancer|Stage IIB Pancreatic Cancer|Stage III Pancreatic Cancer|Stage IV Pancreatic Cancer|Unresectable Pancreatic Carcinoma
|
January 18, 2019 | Phase 1 |
NCT04964583 | Coordinación de Investigación en Salud, Mexico|Ultra Laboratorios SA. de CV. |
Covid19
|
January 20, 2021 | Phase 2|Phase 3 |
NCT04363450 | Louisiana State University Health Sciences Center in New Orleans|Lafayette General Health|University of Louisiana at Lafayette |
COVID-19|Corona Virus Infection|Wuhan Coronavirus|Prophylaxis|Healthcare Worker|Sars-CoV2|Hydroxychloroquine
|
April 27, 2020 | Phase 3 |
NCT04438837 | Rambam Health Care Campus |
Coronavirus Disease 2019 (COVID-19)|Post-Exposure Prophylaxis
|
July 2020 | Not Applicable |
NCT04330144 | Gangnam Severance Hospital |
Contact Person From COVID-19 Confirmed Patient
|
April 1, 2020 | Phase 3 |
NCT04464759 | Ravi Amaravadi, MD|Bristol-Myers Squibb|Abramson Cancer Center of the University of Pennsylvania |
Melanoma
|
October 21, 2020 | Phase 1|Phase 2 |
NCT04338698 | Shehnoor Azhar|University of Health Sciences Lahore |
COVID 19
|
April 22, 2020 | Phase 3 |
NCT04400019 | University of Malaga|Instituto de Investigacion Biomedica de Malaga|Carlos III Health Institute |
Sars-CoV2|Coronavirus Infection|Prevention & Control|Nursing Home|Hydroxychloroquine
|
September 2020 | Phase 2|Phase 3 |
NCT04343768 | Shahid Beheshti University of Medical Sciences |
COVID-19
|
April 9, 2020 | Phase 2 |
NCT01689987 | OHSU Knight Cancer Institute|National Cancer Institute (NCI) |
Recurrent Plasma Cell Myeloma|Refractory Plasma Cell Myeloma
|
September 2012 | Phase 1 |
NCT01232660 | St Stephens Aids Trust |
HIV Infection
|
October 2010 | Phase 1 |
NCT00813423 | National Cancer Institute (NCI) |
Adult Solid Neoplasm
|
January 27, 2010 | Phase 1 |
NCT04392973 | King Abdullah International Medical Research Center |
COVID19
|
May 21, 2020 | Not Applicable |
NCT04340349 | Instituto Nacional de Rehabilitacion |
Hydroxychloroquine|Antimalarials|Enzyme Inhibitors|Antirheumatic Agents
|
February 1, 2021 | Early Phase 1 |
NCT00311883 | Vanderbilt University |
Cystic Fibrosis
|
March 2006 | Phase 1 |
NCT01941095 | Hoffmann-La Roche |
Rheumatoid Arthritis
|
November 20, 2013 | Phase 3 |
NCT04022421 | Assiut University |
Behcet´s Syndrome, Vascular Type
|
October 1, 2018 | Not Applicable |
NCT05051137 | Karolinska Institutet|Harvard Medical School (HMS and HSDM) |
Rheumatoid Arthritis
|
January 12, 2006 | |
NCT00714181 | Abramson Cancer Center of the University of Pennsylvania|National Cancer Institute (NCI) |
Unspecified Adult Solid Tumor, Protocol Specific
|
June 2008 | Phase 1 |
NCT03085940 | Indonesia University |
Rheumatoid Arthritis
|
January 20, 2017 | Not Applicable |
NCT01266057 | M.D. Anderson Cancer Center |
Advanced Cancers
|
April 28, 2011 | Phase 1 |
NCT01510119 | Abramson Cancer Center of the University of Pennsylvania|University of Pittsburgh|Rutgers Cancer Institute of New Jersey |
Metastatic Clear Cell Renal Cell Carcinoma
|
September 2011 | Phase 1|Phase 2 |
NCT04527549 | ECOG-ACRIN Cancer Research Group|National Cancer Institute (NCI)|Eastern Cooperative Oncology Group |
Clinical Stage IV Cutaneous Melanoma AJCC v8|Locally Advanced Melanoma|Pathologic Stage IIIC Cutaneous Melanoma AJCC v8|Pathologic Stage IV Cutaneous Melanoma AJCC v8|Unresectable Melanoma
|
October 23, 2020 | Phase 2 |
NCT03081702 | University Health Network, Toronto |
Platinum-resistant Epithelial Ovarian Cancer
|
July 25, 2017 | Phase 1|Phase 2 |
NCT01128296 | Amer Zureikat|National Institutes of Health (NIH)|University of Pittsburgh |
Pancreatic Cancer
|
October 2010 | Phase 1|Phase 2 |
NCT04624269 | Shanghai First Maternity and Infant Hospital|Xinhua Hospital, Shanghai Jiao Tong University School of Medicine|Shanghai Jiao Tong University Affiliated Sixth People´s Hospital|Fudan University|Zhejiang Provincial People´s Hospital|Zhejiang Provincial Tongde Hospital |
Antiphospholipid Syndrome|Recurrent Miscarriage
|
December 1, 2020 | Phase 4 |
NCT04132505 | M.D. Anderson Cancer Center|National Cancer Institute (NCI) |
Metastatic Pancreatic Adenocarcinoma|Stage IV Pancreatic Cancer AJCC v8
|
October 22, 2019 | Phase 1 |
NCT04787991 | Parker Institute for Cancer Immunotherapy|Bristol-Myers Squibb|Cancer Research Institute, New York City|PsiOxus Therapeutics Ltd |
Metastatic Pancreatic Adenocarcinoma
|
August 9, 2021 | Phase 1 |
NCT02126683 | National Taiwan University Hospital |
Hashimoto´s Thyroiditis
|
April 2014 | Not Applicable |
NCT04335084 | ProgenaBiome|DSCS CRO |
COVID-19|Coronavirus Infection|Sars-CoV2|Corona Virus Infection|COVID|Coronavirus|Coronavirus-19|Coronavirus 19
|
June 22, 2020 | Phase 2 |
NCT04329611 | Dr. Michael Hill|Alberta Health services|University of Alberta|University of Calgary|Calgary Health Trust|Alberta Innovates Health Solutions|Government of Alberta |
COVID-19
|
April 13, 2020 | Phase 3 |
NCT01506973 | Abramson Cancer Center of the University of Pennsylvania |
Advanced Adenocarcinoma|Metastatic Adenocarcinoma
|
December 2011 | Phase 1|Phase 2 |
NCT04394442 | Samah Lutfy|Zagazig University |
COVID-19
|
March 21, 2020 | Phase 2 |
NCT04363866 | Oregon Health and Science University|OHSU Knight Cancer Institute |
COVID-19|SARS-CoV-2
|
August 2020 | Phase 2 |
NCT04328272 | Prof. Dr. Umar Farooq|Ayub Medical College, Abbottabad |
COVID19
|
March 28, 2020 | Phase 3 |
NCT04379492 | Memorial Sloan Kettering Cancer Center |
COVID-19|COVID19|Sars-CoV2|SARS-Cov-2
|
May 5, 2020 | Phase 2 |
NCT04669197 | HonorHealth Research Institute |
Untreated Resectable Pancreatic Adenocarcinoma|Borderline Resectable Pancreatic Adenocarcinoma|Locally Advanced Pancreatic Adenocarcinoma
|
December 1, 2020 | Phase 2 |
NCT04342156 | Tan Tock Seng Hospital|National Center for Infectious Diseases|Singapore Clinical Research Institute|Singapore Eye Research Institute|Saw Swee Hock School of Public Health|Duke-NUS Graduate Medical School|Netherlands: Ministry of Health, Welfare and Sports |
Coronavirus Infection|Hydroxychloroquine Adverse Reaction
|
April 2020 | Phase 3 |
NCT04524702 | Emory University|National Cancer Institute (NCI) |
Advanced Pancreatic Adenocarcinoma|Metastatic Pancreatic Adenocarcinoma|Stage IV Pancreatic Cancer AJCC v8
|
September 14, 2020 | Phase 2 |
NCT04011410 | Andrew C. James, MD|University of Kentucky |
Prostate Cancer Recurrent
|
December 3, 2019 | Phase 2 |
NCT05084872 | University Hospital, Toulouse |
Mastocytosis
|
October 2021 | Phase 2|Phase 3 |
NCT04374942 | Megan Landes|University Health Network, Toronto |
Pre-Exposure Prophylaxis|Coronavirus|SARS-CoV 2
|
April 30, 2020 | Phase 3 |
NCT04376814 | Baqiyatallah Medical Sciences University |
COVID-19|Favipiravir|Kaletra|Hydroxychloroquine|Lopinavir+Ritonavir
|
March 29, 2020 | Not Applicable |
NCT03636152 | VA Office of Research and Development |
Chronic Kidney Disease|Cardiovascular Disease|Inflammation|Atherosclerosis|Aortic Stiffness
|
December 14, 2018 | Phase 2 |
NCT03344172 | Nathan Bahary, MD|Pfizer|National Cancer Institute (NCI)|University of Pittsburgh |
Pancreatic Cancer Resectable
|
December 13, 2017 | Phase 2 |
NCT04349228 | Abderrahmane Mami Hospital|Eshmoun Clinical Research Center|Datametrix |
COVID19|Sars-CoV2|Hydroxychloroquine|Prophylaxis|Healthcare Worker
|
April 28, 2020 | Phase 3 |
NCT04466540 | Hospital Alemão Oswaldo Cruz|EMS S+A|Hospital do Coracao|Hospital Israelita Albert Einstein|Hospital Sirio-Libanes|Hospital Moinhos de Vento|Brazilian Research In Intensive Care Network |
COVID-19
|
May 12, 2020 | Phase 4 |
NCT03592823 | First Affiliated Hospital of Harbin Medical University |
Atrial Fibrillation
|
August 1, 2018 | Phase 4 |
NCT03979651 | Hospices Civils de Lyon |
Metastatic NRAS Melanoma
|
October 15, 2019 | Not Applicable |
NCT02722369 | University College, London |
Small Cell Lung Cancer
|
March 14, 2017 | Phase 2 |
NCT02451748 | University of Illinois at Chicago|UCB Pharma |
Rheumatoid Arthritis
|
August 2015 | Phase 4 |
NCT05518110 | Cancer Trials Ireland|Novartis |
Pancreatic Cancer
|
September 15, 2022 | Phase 2 |
NCT02303405 | Charles Drew University of Medicine and Science |
Diabetes Mellitus Type 2 With Hyperglycemia
|
November 2014 | Phase 2 |
NCT00568880 | Abramson Cancer Center of the University of Pennsylvania |
Multiple Myeloma and Plasma Cell Neoplasm
|
September 8, 2010 | Phase 1 |
NCT04332991 | Massachusetts General Hospital|National Heart, Lung, and Blood Institute (NHLBI) |
Coronavirus|Acute Respiratory Infection|SARS-CoV Infection
|
April 2, 2020 | Phase 3 |
NCT04954040 | Maimónides Biomedical Research Institute of Córdoba |
Acute Respiratory Distress Syndrome|Covid19
|
February 10, 2021 | Phase 2 |
NCT04435808 | University of New Mexico |
COVID-19
|
April 14, 2020 | Phase 1|Phase 2 |
NCT04374552 | Rutgers, The State University of New Jersey |
SARS-CoV-2 Infection
|
May 5, 2020 | Phase 2 |
NCT04434144 | Upazila Health & Family Planning Officer´s (UHFPO) Office, Chakoria, Cox´s Bazar |
Ivermectin|Hydroxychloroquine|COVID19
|
May 2, 2020 | |
NCT03791827 | Xiqiang Dang|The Children´s Hospital Affiliated to Suzhou University|Shandong Provincial Hospital|Guizhou Provincial People´s Hospital|LanZhou University|The First Affiliated Hospital of Inner Mongolia Medical College|People´s Hospital of Zhangjiajie|Puyang Oilfield General Hospital|The First Affiliated Hospital of Anhui Medical University|Guizhou Maternal and Child Health Care Hospital|The Second Affiliated Hospital & Yuying Children´s Hospital of Wenzhou Medical University|Shenzhen Children´s Hospital|The Second Affiliated Hospital of Harbin Medical University|Yichang Central People´s Hospital|Xian Children´s Hospital|Wuhan Children´s Hospital, Tongji Medical College, Huazhong University of Science & Technology|The First People´s Hospital of Yunnan|The First Affiliated Hospital of Xiamen University|The First Affiliated Hospital of Xinxiang Medical College|Shanxi Provincial Maternity and Children´s Hospital|Liaocheng People´s Hospital|Fujian Provincial Hospital|First Affiliated Hospital of Guangxi Medical University|Second Hospital of Lanzhou University|Guangzhou First People´s Hospital|The Second Hospital of Shandong University|Children´s Hospital of Hebei Province|Beijing Children´s Hospital|Zhengzhou Children´s Hospital|The Children´s Hospital of Chongqing Medical University|Wuxi Children´s Hospital|The Children´s Hospital of Fudan University|Shanghai Children´s Medical Center|Qilu Children´s Hospital of Shandong University|Second Xiangya Hospital of Central South University |
Lupus Nephritis|Children|Steroid|Immunosuppressive Treatment
|
December 1, 2018 | |
NCT04322396 | Chronic Obstructive Pulmonary Disease Trial Network, Denmark |
Virus Diseases|Infection Viral|Corona Virus Infection
|
April 6, 2020 | Phase 2 |
NCT05110651 | Nicholas Carlson|Rigshospitalet, Denmark |
COVID-19|End Stage Renal Disease
|
April 10, 2020 | Phase 4 |
NCT04497519 | University Medical Center Groningen |
Covid19
|
September 15, 2020 | Phase 1 |
NCT01272310 | Sheba Medical Center |
Chronic Hepatitis C
|
January 2011 | Phase 1|Phase 2 |
NCT04261517 | Shanghai Public Health Clinical Center |
Pneumonia, Pneumocystis|Coronavirus|COVID-19
|
February 6, 2020 | Phase 3 |
NCT05237843 | Ain Shams University |
Recurrent Pregnancy Loss
|
March 1, 2022 | Phase 1 |
NCT01480154 | National Cancer Institute (NCI) |
Advanced Malignant Solid Neoplasm|Stage III Cutaneous Melanoma AJCC v7|Stage III Prostate Cancer AJCC v7|Stage III Renal Cell Cancer AJCC v7|Stage IIIA Cutaneous Melanoma AJCC v7|Stage IIIB Cutaneous Melanoma AJCC v7|Stage IIIC Cutaneous Melanoma AJCC v7|Stage IV Cutaneous Melanoma AJCC v6 and v7|Stage IV Prostate Cancer AJCC v7|Stage IV Renal Cell Cancer AJCC v7
|
November 23, 2011 | Phase 1 |
NCT05026801 | Iterum Therapeutics, International Limited|Waterbury Hospital |
Respiratory Tract Infection Viral
|
February 8, 2021 | Phase 3 |
NCT04341870 | Assistance Publique - Hôpitaux de Paris |
COVID19|SARS-CoV-2 Infection
|
April 11, 2020 | Phase 2|Phase 3 |
NCT04332094 | Fundació Institut de Recerca de l´Hospital de la Santa Creu i Sant Pau|Instituto de Salud Carlos III |
COVID-19
|
April 2, 2020 | Phase 2 |
NCT04347980 | Centre Chirurgical Marie Lannelongue |
Respiratory Distress Syndrome, Adult|COVID-19
|
April 17, 2020 | Phase 3 |
NCT04373044 | University of Southern California|National Cancer Institute (NCI) |
Symptomatic COVID-19 Infection Laboratory-Confirmed
|
May 1, 2020 | Phase 2 |
NCT04201457 | Pediatric Brain Tumor Consortium |
Low Grade Glioma (LGG) of Brain With BRAF Aberration|High Grade Glioma (HGG) of the Brain With BRAF Aberration|Low Grade Glioma of Brain With Neurofibromatosis Type 1
|
November 20, 2019 | Phase 1|Phase 2 |
NCT04321616 | Oslo University Hospital |
SARS-CoV Infection|COVID 19|Acute Respiratory Distress Syndrome ARDS
|
March 28, 2020 | Phase 2|Phase 3 |
NCT02444728 | Chinese SLE Treatment And Research Group|Peking Union Medical College Hospital |
Thrombocytopenia
|
July 2015 | Phase 3 |
NCT01537315 | University of Arkansas |
Kidney Failure, Chronic|Cardiovascular Disease|Arteriosclerosis
|
February 2012 | Phase 2 |
NCT03671174 | RenJi Hospital|The First Affiliated Hospital of Anhui Medical University|China-Japan Union Hospital, Jilin University|Wuxi No. 2 People´s Hospital|The First Affiliated Hospital with Nanjing Medical University|Xiangya Hospital of Central South University |
Undifferentiated Connective Tissue Disease|Recurrent Pregnancy Loss
|
August 2, 2019 | Not Applicable |
NCT04347512 | University Hospital, Strasbourg, France |
Sars-CoV-2, Community-Acquired Pneumonia,COVID-19
|
June 2, 2020 | Phase 3 |
NCT04460547 | Qassim University |
COVID-19
|
July 25, 2020 | |
NCT04329832 | Intermountain Health Care, Inc.|University of Utah |
COVID-19
|
March 30, 2020 | Phase 2 |
NCT04383717 | Cairo University |
Respiratory Tract Infections
|
May 5, 2020 | Phase 3 |
NCT03025087 | Duke University |
Individuals Undergoing Cardiac and General Surgery
|
June 19, 2017 | Phase 4 |
NCT04336332 | Rutgers, The State University of New Jersey |
SARS-CoV-2|COVID-19
|
April 1, 2020 | Phase 2 |
NCT04334967 | Providence Health & Services|Center for Outcomes Research and Education|Providence Cancer Center, Earle A. Chiles Research Institute |
COVID-19|Corona Virus Infection|SARS-CoV-2|2019-nCoV|2019 Novel Coronavirus
|
March 30, 2020 | Phase 4 |
NCT04382625 | Kootenai Health|Washington State University |
SARS-CoV-2 Pneumonia|COVID-19
|
October 2020 | Phase 4 |
NCT04354428 | University of Washington|Bill and Melinda Gates Foundation |
COVID-19|SARS-CoV-2
|
April 16, 2020 | Phase 2|Phase 3 |
NCT04341207 | Gustave Roussy, Cancer Campus, Grand Paris |
Cancer & COVID 19
|
April 3, 2020 | Phase 2 |
NCT04333225 | Baylor Research Institute |
COVID-19
|
April 3, 2020 | Phase 2 |
NCT04316377 | University Hospital, Akershus |
Corona Virus Infection
|
March 25, 2020 | Phase 4 |
NCT03414502 | University of Nebraska |
Rheumatoid Arthritis
|
August 2007 | Phase 3 |
NCT01573754 | The University of Texas Medical Branch, Galveston |
Porphyria Cutanea Tarda
|
March 21, 2006 | Phase 2 |
NCT04858633 | Postgraduate Institute of Medical Education and Research |
Covid19|COVID-19 Prevention
|
March 22, 2021 | Phase 3 |
NCT04351724 | Medical University of Vienna|Kaiser Franz Josef Hospital|SMZ-Ost Donauspital|Otto Wagner Hospital|Hospital Hietzing|Wilhelminenspital Vienna|Medical University Innsbruck|Medical University of Graz|Kepler University Hospital |
COVID-19
|
April 16, 2020 | Phase 2|Phase 3 |
NCT04344379 | Assistance Publique - Hôpitaux de Paris |
SARS-CoV-2 Infection
|
April 17, 2020 | Phase 3 |
NCT03400254 | Abramson Cancer Center of the University of Pennsylvania|Translational Breast Cancer Research Consortium|Pfizer|Hoosier Cancer Research Network|Breast Cancer Research Foundation |
Breast Cancer
|
February 26, 2019 | Phase 1|Phase 2 |
NCT04377646 | Military Hospital of Tunis|UR17DN02 : Autoimmune Diseases Research Unit|Dacima Consulting |
Sars-CoV2|COVID19
|
May 4, 2020 | Phase 3 |
NCT01006369 | Rutgers, The State University of New Jersey|National Cancer Institute (NCI) |
Colorectal Cancer
|
May 2009 | Phase 2 |
NCT03540810 | University Hospital, Angers |
Primary Antiphospholipid Syndrome
|
August 15, 2018 | Phase 3 |
NCT04981145 | Second Affiliated Hospital, School of Medicine, Zhejiang University |
Primary Sjögren´s Syndrome
|
January 14, 2022 | Phase 4 |
NCT04735068 | Abramson Cancer Center of the University of Pennsylvania|Pfizer |
Non-Small Cell Lung Cancer|KRAS Mutation-Related Tumors
|
April 9, 2021 | Phase 2 |
NCT04346667 | Government of Punjab, Specialized Healthcare and Medical Education Department|Mayo Hospital Lahore|Services Institute of Medical Sciences, Pakistan|Pakistan Kidney and Liver Institute|Forman Christian College, Pakistan|Harvard School of Public Health (HSPH) |
SARS-CoV-2|Coronavirus Infection|Asymptomatic Condition|COVID-19
|
April 14, 2020 | Phase 4 |
NCT04214418 | Columbia University|Genentech, Inc. |
Gastrointestinal Cancer
|
February 12, 2020 | Phase 1|Phase 2 |
NCT04355026 | General and Teaching Hospital Celje |
Covid-19
|
April 10, 2020 | Phase 4 |
NCT04532346 | Children´s Hospital of Fudan University |
Interstitial Lung Disease|Surfactant Dysfunction
|
August 2022 | Early Phase 1 |
NCT04429867 | WellStar Health System |
COVID-19
|
May 7, 2020 | Phase 4 |
NCT04522466 | Centre Hospitalier Universitaire de Saint Etienne|CHU Saint-Etienne - Laboratoire de Pharmacologie - Toxicologie - Gaz du sang |
Sars-CoV2
|
April 3, 2020 | Phase 3 |
NCT04443725 | Cairo University |
COVID-19
|
July 2020 | Phase 2|Phase 3 |
NCT04421664 | McGill University Health Centre+Research Institute of the McGill University Health Centre|University of Manitoba|University of Alberta|University of British Columbia|McMaster University|Lawson Health Research Institute|Eastern Health|University of Minnesota |
Corona Virus Infection|SARS-CoV Infection|Coronavirus
|
March 25, 2020 | Phase 3 |
NCT02756546 | Cairo University |
Systemic Lupus Erythematosis
|
September 2014 | Phase 1|Phase 2 |
NCT03377179 | RedHill Biopharma Limited |
Cholangiocarcinoma|Cholangiocarcinoma Non-resectable|Cholangiocarcinoma, Perihilar|Cholangiocarcinoma, Extrahepatic|Cholangiocarcinoma, Intrahepatic
|
March 7, 2018 | Phase 2 |
NCT04352946 | GeoSentinel Foundation |
Prophylaxis|COVID-19|Health Care Worker|Hydroxychloroquine
|
April 24, 2020 | Phase 3 |
NCT04873895 | Abramson Cancer Center of the University of Pennsylvania|Pfizer |
Colorectal Neoplasms Malignant
|
January 24, 2022 | Phase 1 |
NCT04359953 | University Hospital, Strasbourg, France |
COVID-19 Infection
|
April 25, 2020 | Phase 3 |
NCT03813771 | University of Leeds|Samsung Bioepis Co., Ltd. |
Rheumatoid Arthritis
|
March 2019 | Phase 4 |
NCT04394182 | Fundacion GenesisCare|Hospital La Milagrosa|Hospital Vithas Valencia Consuelo |
Pneumonia, Viral|Cytokine Storm
|
April 21, 2020 | Not Applicable |
NCT00946790 | Sandoz |
Immunosuppression|Rheumatism
|
July 1993 | Phase 1 |
NCT04351620 | University of Chicago |
COVID-19
|
April 2020 | Phase 1 |
NCT02433184 | University of Leeds |
Rheumatoid Arthritis
|
July 2011 | Phase 4 |
NCT02735707 | UMC Utrecht|Australian and New Zealand Intensive Care Research Centre|Medical Research Institute of New Zealand|Unity Health|Berry Consultants|Global Coalition for Adaptive Research|University of Pittsburgh Medical Center|Intensive Care National Audit & Research Centre|St. Marianna University School of Medicine|National Intensive Care Surveillance MORU |
Community-acquired Pneumonia, Influenza, COVID-19
|
April 11, 2016 | Phase 3 |
NCT04860284 | Makerere University |
Covid19
|
September 18, 2020 | Phase 2 |
NCT01417403 | Virginia Commonwealth University|National Cancer Institute (NCI) |
Bone Metastases|Unspecified Adult Solid Tumor, Protocol Specific
|
August 2011 | Phase 1 |
NCT04414241 | Universidad Peruana Cayetano Heredia |
SARS-CoV-2
|
June 25, 2020 | Phase 3 |
NCT04368351 | University of Roma La Sapienza |
COVID|Pneumonia|Diarrhea
|
March 1, 2020 | |
NCT00771056 | Northwell Health |
B-Cell Chronic Lymphocytic Leukemia
|
July 2008 | Phase 2 |
NCT00259610 | University of Alabama at Birmingham|Amgen|Barr Laboratories|Pfizer |
Rheumatoid Arthritis
|
May 2004 | Phase 4 |
NCT03754179 | Universitair Ziekenhuis Brussel|University Hospital, Ghent |
Melanoma
|
January 23, 2018 | Phase 1|Phase 2 |
NCT04385264 | Center for Primary Care and Public Health (Unisante), University of Lausanne, Switzerland |
COVID-19
|
January 2022 | Phase 2|Phase 3 |
NCT04362332 | UMC Utrecht|ZonMw: The Netherlands Organisation for Health Research and Development |
COVID-19
|
April 14, 2020 | Phase 4 |
NCT04353271 | University of South Alabama |
Covid 19|Corona Virus Infection
|
April 17, 2020 | Phase 2|Phase 3 |
NCT02124681 | University of Pittsburgh |
Insulin Resistance
|
April 2014 | Phase 1 |
NCT02200146 | University of Milano Bicocca|Agenzia Italiana del Farmaco |
Pulmonary Sarcoidosis
|
March 2009 | Phase 3 |
NCT04346329 | Universidad Nacional de Colombia|Fundación Salud de los Andes |
COVID
|
March 30, 2020 | Phase 3 |
NCT04590274 | International Brain Research Foundation |
Covid19|SARS (Severe Acute Respiratory Syndrome)
|
November 2020 | Phase 1 |
NCT04395768 | National Institute of Integrative Medicine, Australia |
COVID19
|
September 9, 2020 | Phase 2 |
NCT04446104 | National University Hospital, Singapore |
Covid-19
|
May 13, 2020 | Phase 3 |
NCT04354441 | Sir Mortimer B. Davis - Jewish General Hospital |
COVID-19|SARS-CoV-2|Pregnant Women|Hydroxychloroquine
|
May 2020 | Phase 2 |
NCT04077957 | Nanfang Hospital of Southern Medical University |
Ankylosing Spondylitis|Spondyloarthritis
|
October 7, 2019 | Phase 4 |
NCT00909831 | Abramson Cancer Center of the University of Pennsylvania|National Cancer Institute (NCI) |
Unspecified Adult Solid Tumor, Protocol Specific
|
October 2008 | Phase 1 |
NCT02615938 | Matthias Griese|Ludwig-Maximilians - University of Munich |
Interstitial Lung Disease|Diffuse Parenchymal Lung Disease|Children´s Interstitial Lung Disease
|
April 2015 | Phase 2 |
NCT04336748 | Medical University of Vienna |
Sars-CoV2|Infection Viral|Healthcare Worker|Prophylaxis
|
April 2020 | Phase 3 |
NCT04153201 | National and Kapodistrian University of Athens |
Antiphospholipid Syndrome
|
January 15, 2013 | Not Applicable |
NCT04981379 | Health Institutes of Turkey |
Covid19
|
November 16, 2020 | Phase 3 |
NCT04386057 | Kimberly Perez|Eli Lilly and Company|Dana-Farber Cancer Institute |
Pancreatic Cancer|Advanced Cancer
|
May 27, 2020 | Phase 2 |
NCT04328467 | University of Minnesota |
COVID-19|Corona Virus Infection|ARDS|Acute Respiratory Distress Syndrome
|
April 6, 2020 | Phase 3 |
NCT04391127 | Centenario Hospital Miguel Hidalgo |
COVID-19
|
May 4, 2020 | Phase 3 |
NCT04755322 | Assiut University |
Hydroxychloroquine
|
March 1, 2021 | Not Applicable |
NCT04363827 | Istituto Scientifico Romagnolo per lo Studio e la cura dei Tumori|University of Bologna |
COVID19|Hydroxychloroquine|Prophylaxis|Treatment|SARS-CoV-2
|
May 14, 2020 | Phase 2 |
NCT04345653 | Hackensack Meridian Health |
Covid19
|
April 14, 2020 | Phase 2 |
NCT00728845 | University of Medicine and Dentistry of New Jersey|National Cancer Institute (NCI)|Rutgers, The State University of New Jersey |
Lung Cancer
|
June 16, 2008 | Phase 1|Phase 2 |
NCT02316340 | The University of Texas Health Science Center at San Antonio |
Colorectal Cancer
|
February 11, 2015 | Phase 2 |
NCT00632866 | Assistance Publique - Hôpitaux de Paris|Sanofi |
Primary Sjögren´s Syndrome
|
March 2008 | Phase 3 |
NCT00962845 | Rutgers, The State University of New Jersey|National Cancer Institute (NCI)|Rutgers Cancer Institute of New Jersey |
Melanoma (Skin)
|
September 2010 | Early Phase 1 |
NCT01833845 | BioLineRx, Ltd. |
Hepatitis C
|
April 2013 | Phase 1|Phase 2 |
NCT01273805 | Dana-Farber Cancer Institute|Brigham and Women´s Hospital|Massachusetts General Hospital |
Pancreatic Cancer
|
January 2011 | Phase 2 |
NCT01207739 | Radboud University Medical Center|Sint Maartenskliniek|ZonMw: The Netherlands Organisation for Health Research and Development |
Lyme Disease|Borrelia Infection
|
September 2010 | Phase 4 |
NCT03856866 | The Hospital for Sick Children |
Zellweger Syndrome|Peroxisome Biogenesis Disorders
|
January 11, 2019 | Phase 2 |
NCT04318015 | National Institute of Respiratory Diseases, Mexico |
COVID-19|Severe Acute Respiratory Syndrome
|
April 14, 2020 | Phase 3 |
NCT04316494 | Guy´s and St Thomas´ NHS Foundation Trust|Medical Research Council |
ANCA Associated Vasculitis|Microscopic Polyangiitis|Churg-Strauss Syndrome|Wegener Granulomatosis
|
December 17, 2020 | Phase 4 |
NCT00413361 | Assistance Publique - Hôpitaux de Paris|Sanofi-Synthelabo |
Systemic Lupus Erythematosus
|
June 2007 | Phase 4 |
NCT05626348 | Qilu Hospital of Shandong University |
Arthritis, Rheumatoid
|
December 22, 2021 | Phase 4 |
NCT04566133 | National Cancer Institute (NCI)|National Institutes of Health Clinical Center (CC) |
Bile Duct Cancer|Biliary Cancer|Biliary Tract Neoplasms|Cholangiocarcinoma
|
February 15, 2022 | Phase 2 |
NCT04318444 | Columbia University |
COVID-19|Corona Virus Infection
|
March 29, 2020 | Phase 2|Phase 3 |
NCT02714634 | University Hospital, Strasbourg, France |
Rheumatoid Arthritis|Insufficient Response to Methotrexate or Leflunomide
|
March 30, 2016 | Phase 4 |
NCT04361318 | Tanta University |
COVID-19
|
May 2020 | Phase 2|Phase 3 |
NCT01206530 | Abramson Cancer Center of the University of Pennsylvania |
Rectal Cancer|Colon Cancer|Metastasis|Adenocarcinoma
|
September 2010 | Phase 1|Phase 2 |
NCT04458948 | University of New Mexico |
COVID-19
|
March 24, 2020 | Phase 2 |
NCT03019926 | University Hospital Center of Martinique |
Systemic Lupus, Skin Lupus
|
January 19, 2017 | |
NCT01227135 | Lynn McMahon|Medical Research Council|CRUK Trials unit Glasgow|University of Glasgow |
Leukemia
|
March 2010 | Phase 2 |
NCT04341441 | Henry Ford Health System |
COVID-19|Coronavirus|Coronavirus Infections|SARS-CoV 2
|
April 7, 2020 | Phase 3 |
NCT03215264 | Abramson Cancer Center of the University of Pennsylvania |
Colorectal Cancer
|
October 2, 2017 | Phase 1|Phase 2 |
NCT04437693 | Hamad Medical Corporation |
COVID 19
|
August 31, 2020 | Phase 2|Phase 3 |
NCT01897116 | Abramson Cancer Center of the University of Pennsylvania |
Melanoma
|
June 2013 | Phase 1 |
NCT02930343 | Jawaharlal Institute of Postgraduate Medical Education & Research |
Rheumatoid Arthritis
|
September 2016 | Phase 3 |
NCT04322123 | Hospital do Coracao|Hospital Israelita Albert Einstein|Hospital Sirio-Libanes|Brazilian Research In Intensive Care Network|EMS |
Coronavirus Infections
|
April 1, 2020 | Phase 3 |
NCT04303507 | University of Oxford |
COVID19|Coronavirus|Acute Respiratory Illnesses
|
April 29, 2020 | Not Applicable |
NCT00031824 | Children´s Oncology Group|National Cancer Institute (NCI) |
Graft Versus Host Disease
|
April 2002 | Phase 3 |
NCT04403100 | Cardresearch|Cardresearch - Cardiologia Assistencial e de Pesquisa LTDA|Cytel Inc. |
COVID-19|Coronavirus Infection|Virus Disease|Acute Respiratory Infection|SARS-CoV Infection
|
June 3, 2020 | Phase 3 |
NCT04349592 | Hamad Medical Corporation |
Covid19
|
April 14, 2020 | Not Applicable |
NCT04369742 | NYU Langone Health|State University of New York - Downstate Medical Center |
COVID-19
|
April 15, 2020 | Phase 2 |
NCT04370015 | Services Institute of Medical Sciences, Pakistan |
SARS-CoV-2|Healthcare Workers
|
May 15, 2020 | Not Applicable |
NCT04575558 | Latin American Cooperative Oncology Group|Oncoclínicas |
Sars-CoV2
|
June 30, 2020 | Phase 2 |
NCT01396200 | Abramson Cancer Center of the University of Pennsylvania |
Myeloma
|
June 2011 | Early Phase 1 |
NCT01550367 | Leonard Appleman|Prometheus Laboratories|University of Pittsburgh |
Metastatic Renal Cell Carcinoma
|
March 2012 | Phase 1|Phase 2 |
NCT04359537 | Shaheed Zulfiqar Ali Bhutto Medical University |
COVID 19
|
May 1, 2020 | Phase 2 |
NCT02603146 | National Institute of Allergy and Infectious Diseases (NIAID)|Autoimmunity Centers of Excellence |
Healthy Participants|Rheumatoid Arthritis (RA) Prevention
|
April 27, 2016 | Phase 2 |
NCT02421575 | Rutgers, The State University of New Jersey|National Cancer Institute (NCI)|Rutgers Cancer Institute of New Jersey |
Prostate Carcinoma
|
July 2012 | Early Phase 1 |
NCT04005768 | Universitaire Ziekenhuizen KU Leuven |
Obesity
|
August 1, 2019 | Phase 4 |
NCT01026844 | Massachusetts General Hospital|Genentech, Inc. |
Non-small Cell Lung Cancer
|
July 2007 | Phase 1 |
NCT03037437 | The University of Texas Health Science Center at San Antonio |
Hepatocellular Cancer
|
February 16, 2017 | Phase 2 |
NCT04161339 | Instituto de Cardiologia do Rio Grande do Sul|Hospital de Clinicas de Porto Alegre |
Cardiovascular Diseases|Endothelial Dysfunction|Sleep Apnea|Atherosclerosis|Coronary Artery Disease
|
July 1, 2019 | Phase 4 |
NCT04371926 | Texas Cardiac Arrhythmia Research Foundation |
COVID-19
|
June 2020 | Not Applicable |
NCT01495403 | Mayo Clinic |
Liver Cirrhosis|Muscle Cramps
|
December 2011 | Early Phase 1 |
NCT03428945 | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)|Juvenile Diabetes Research Foundation |
Type1 Diabetes Mellitus
|
August 15, 2018 | Phase 2 |
NCT04315948 | Institut National de la Santé Et de la Recherche Médicale, France |
Corona Virus Infection
|
March 22, 2020 | Phase 3 |
NCT04340544 | University Hospital Tuebingen|Robert Bosch Medical Center|Universitätsklinikum Hamburg-Eppendorf|Bernhard Nocht Institute for Tropical Medicine |
COVID-19
|
April 22, 2020 | Phase 2 |
NCT04477083 | Mansoura University |
Covid19|Hydroxychloroquine Adverse Reaction
|
July 15, 2020 | Not Applicable |
NCT05287321 | Yoo-min Kim|Ministry of Health & Welfare, Korea|Chung-Ang University Hosptial, Chung-Ang University College of Medicine |
Preeclampsia
|
April 15, 2022 | Phase 3 |
NCT03015324 | Peng Wang, MD PhD|University of Kentucky |
Solid Tumor
|
August 8, 2017 | Phase 1 |
NCT04714515 | University of Sargodha|Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine|Shaukat Khanum Memorial Cancer Hospital & Research Centre|Shanghai Jiao Tong University School of Medicine|Teesside University |
Covid19|SARS-CoV-2 Infection
|
February 20, 2020 | |
NCT04335552 | Duke University |
SARS-CoV-2
|
April 17, 2020 | Phase 2 |
NCT04308668 | University of Minnesota|McGill University Health Centre+Research Institute of the McGill University Health Centre|University of Manitoba|University of Alberta |
Corona Virus Infection|Acute Respiratory Distress Syndrome|SARS-CoV Infection|Coronavirus|Coronavirus Infections
|
March 17, 2020 | Phase 3 |
NCT04350671 | Shahid Beheshti University of Medical Sciences |
COVID-19
|
April 15, 2020 | Phase 4 |
NCT03305263 | Rigshospitalet, Denmark |
Recurrent Pregnancy Loss
|
January 25, 2018 | Phase 3 |
NCT04390061 | Università Politecnica delle Marche|Azienda Ospedaliera Ospedali Riuniti Marche Nord|Ospedale Civile Santo Spirito, Pescara|Università Magna Grecia, Catanzaro|ASST Papa Giovanni XXIII, Bergamo|Azienda Ospedaliero Universitaria Policlinico Umberto I, Roma|ASST Cremona, Cremona|Fondazione IRCCS Cà Granda, Ospedale Maggiore Policlinico, Milano|Ospedale di Circolo e Fondazione Macchi, Varese |
Pneumonitis, Interstitial|COVID-19
|
June 2020 | Phase 2 |
NCT04228263 | Assiut University |
Hydroxychloroquine
|
January 1, 2020 | Not Applicable |
NCT02913157 | University of Calgary |
Multiple Sclerosis, Primary Progressive
|
November 2016 | Phase 2 |
NCT04746365 | Elaraby Hospital|Shebin El-Kom Teaching Hospital |
Covid19
|
December 6, 2020 | Phase 4 |
NCT01634893 | The University of Texas Health Science Center at San Antonio |
Refractory or Relapsed Solid Tumors
|
June 2012 | Phase 1 |
NCT04371406 | Assistance Publique - Hôpitaux de Paris |
Covid-19
|
April 2020 | Phase 3 |
NCT02595346 | University Hospital, Rouen |
Antiphospholipid Syndrome (APS)
|
June 2016 | Phase 2 |
NCT01494155 | Massachusetts General Hospital |
Pancreatic Cancer
|
December 2011 | Phase 2 |
NCT00977470 | Massachusetts General Hospital|Stanford University|Yale University|University of Maryland, College Park|Genentech, Inc. |
Non-small Cell Lung Cancer
|
October 2009 | Phase 2 |
NCT02910076 | Hadassah Medical Organization |
Diabetes Type Two
|
October 2016 | Phase 1|Phase 2 |
NCT04354649 | AHS Cancer Control Alberta |
Arthritis|Arthralgia
|
July 29, 2021 | Phase 2 |
NCT04307693 | Asan Medical Center |
COVID-19
|
March 11, 2020 | Phase 2 |
NCT00102557 | National Institute of Dental and Craniofacial Research (NIDCR)|National Institutes of Health Clinical Center (CC) |
Lichen Planus, Oral
|
January 2005 | Phase 2 |
NCT03513211 | St Vincent´s Hospital, Sydney |
Prostate Cancer
|
August 23, 2018 | Phase 1|Phase 2 |
NCT04347031 | Burnasyan Federal Medical Biophysical Center |
Pneumonia, Viral|Respiratory Failure
|
April 8, 2020 | Phase 2|Phase 3 |
NCT04350281 | The University of Hong Kong |
COVID
|
April 9, 2020 | Phase 2 |
NCT02631252 | Alison Sehgal, MD, MS|University of Pittsburgh |
Leukemia, Acute Myelogenous
|
August 18, 2016 | Phase 1 |
NCT04569890 | RenJi Hospital |
Rheumatoid Arthritis|Pregnancy Related
|
December 1, 2020 | Not Applicable |
NCT04338906 | Heinrich-Heine University, Duesseldorf|Universitätsklinikum Hamburg-Eppendorf|University Hospital Frankfurt|St. Georg Hospital Leipzig, Germany|Hospital Schwabing Munich, Germany|Missioklinik, Wuerzburg, Germany |
COVID
|
May 2020 | Phase 4 |
NCT04387760 | Royal College of Surgeons in Ireland - Medical University of Bahrain|Ebrahim Khalil Kanoo Community Medical Center|Hereditary blood Disorder Centre - Salmaniya Medical Complex|Mohammed Bin Khalifa Bin Sulman Al Khalifa Cardiac Centre, Awali|Jidhafs COVID-19 Centre|Sitra FICU|Salmaniya Medical Complex- 6th Floor|Salmaniya Medical Complex- Helipad |
SARS-CoV 2|COVID-19
|
August 11, 2020 | Phase 2 |
NCT03032406 | Abramson Cancer Center of the University of Pennsylvania |
Breast Cancer Stage IIB
|
January 23, 2017 | Phase 2 |
NCT04321278 | Hospital Israelita Albert Einstein|EMS|Hospital do Coracao|Hospital Sirio-Libanes|Brazilian Research In Intensive Care Network |
Coronavirus Infections|Pneumonia, Viral
|
March 28, 2020 | Phase 3 |
NCT01842594 | Shin Kong Wu Ho-Su Memorial Hospital |
Sarcoma
|
August 2012 | Phase 2 |
NCT03275870 | Elena Gonzalez Brant, MD|University of Pittsburgh |
Hidradenitis Suppurativa|Hidradenitis|Acne Inversa|Boils|Follicular Occlusion Triad|Follicular Occlusion Tetrad
|
September 28, 2017 | Phase 1|Phase 2 |
NCT04573153 | ScandiBio Therapeutics AB|Istanbul Medipol University Hospital|Istanbul Umraniye Training and Research Hospital|Bakirkoy Dr. Sadi Konuk Research and Training Hospital|Dr. Lutfi Kirdar Kartal Training and Research Hospital|Bagcilar Training and Research Hospital|Kanuni Sultan Suleyman Training and Research Hospital|Alanya Alaaddin Keykubat University Alanya Training and Research Hospital|Canakkale 18 Mart University Health Research and Application Hospital|Monitor CRO |
COVID-19
|
September 21, 2020 | Phase 2|Phase 3 |
NCT04329923 | Ravi Amaravadi, MD|University of Pennsylvania |
COVID-19
|
April 9, 2020 | Phase 2 |
NCT04973566 | Janssen Research & Development, LLC |
Healthy
|
August 31, 2021 | Phase 1 |
NCT00873496 | Ege University |
Sjögren´s Syndrome|Xerostomia
|
January 2005 | |
NCT04350684 | Shahid Beheshti University of Medical Sciences |
COVID-19
|
April 15, 2020 | Phase 4 |
NCT04779047 | October 6 University|Beni-Suef University |
Covid19|Pneumonia
|
October 1, 2020 | Phase 4 |
NCT04345861 | University Hospital, Montpellier |
Coronavirus Infection|Pneumonia, Viral
|
April 11, 2020 | Phase 2|Phase 3 |
Solid
Room temperature in continental US; may vary elsewhere.
Powder | -20°C | 3 years |
---|---|---|
4°C | 2 years | |
In solvent | -80°C | 6 months |
-20°C | 1 month |
1M HCl : 100 mg/mL ( 297.73 mM ; adjust pH to 2 with HCl)
H 2 O : 1.67 mg/mL ( 4.97 mM ; ultrasonic and warming and heat to 60°C)
DMSO : < 1 mg/mL (insoluble or slightly soluble)
Concentration Solvent Mass | 1 mg | 5 mg | 10 mg |
---|
1 mM | 2.9773 mL | 14.8867 mL | 29.7734 mL |
5 mM | 0.5955 mL | 2.9773 mL | 5.9547 mL |
10 mM | 0.2977 mL | 1.4887 mL | 2.9773 mL |